Eli Lilly and Company's CEO Salary
- David A. Ricks Chair, President, and Chief Executive Officer at Eli Lilly and Company, received a total compensation of $36.70 M in 2025.
- Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs at Eli Lilly and Company, received a total compensation of $17.79 M in 2025.
- Anat Hakim Executive Vice President, General Counsel and Secretary at Eli Lilly and Company, received a total compensation of $9.85 M in 2025.
- Lucas Montarce Executive Vice President and Chief Financial Officer at Eli Lilly and Company, received a total compensation of $8.48 M in 2025.
- Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development at Eli Lilly and Company, received a total compensation of $7.59 M in 2025.
Eli Lilly and Company's CEO salary and other executives compensation in 2025 was as follows:
Executive Compensation Summary Table
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| David A. Ricks Chair, President, and Chief Executive Officer | $36.70 M | $29.24 M | $26.57 M |
| Base Salary | $1.70 M | $1.69 M | $1.62 M |
| Incentive Plan Compensation | $6.49 M | $5.71 M | $4.40 M |
| All Other Compensation | $736.20 K | $351.69 K | $263.07 K |
| Stock Award | $23.33 M | $19.75 M | $18.84 M |
| Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs | $17.79 M | $12.64 M | $11.85 M |
| Base Salary | $1.49 M | $1.43 M | $1.33 M |
| Incentive Plan Compensation | $3.25 M | $3.22 M | $2.41 M |
| All Other Compensation | $159.31 K | $206.98 K | $79.85 K |
| Stock Award | $12.00 M | $7.50 M | $7.48 M |
| Anat Hakim Executive Vice President, General Counsel and Secretary | $9.85 M | $7.48 M | $7.01 M |
| Base Salary | $1.00 M | $1.00 M | $980.77 K |
| Incentive Plan Compensation | $2.18 M | $2.25 M | $1.78 M |
| All Other Compensation | $162.57 K | $66.83 K | $58.85 K |
| Stock Award | $6.00 M | $3.95 M | $3.95 M |
| Lucas Montarce Executive Vice President and Chief Financial Officer | $8.48 M | $2.95 M | - |
| Base Salary | $1.00 M | $664.64 K | - |
| Incentive Plan Compensation | $2.18 M | $1.11 M | - |
| All Other Compensation | $60.00 K | $39.88 K | - |
| Stock Award | $5.00 M | $1.07 M | - |
| Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development | $7.59 M | $5.77 M | $4.89 M |
| Base Salary | $920.19 K | $890.39 K | $830.77 K |
| Incentive Plan Compensation | $2.01 M | $2.00 M | $1.50 M |
| All Other Compensation | $72.52 K | $113.06 K | $49.85 K |
| Stock Award | $4.50 M | $2.70 M | $2.42 M |
| Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology | - | $12.64 M | $11.85 M |
| Base Salary | - | $1.43 M | $1.33 M |
| Incentive Plan Compensation | - | $3.22 M | $2.41 M |
| All Other Compensation | - | $206.98 K | $79.85 K |
| Stock Award | - | $7.50 M | $7.48 M |
| Jake Van Naarden Executive Vice President and President, Loxo@Lilly | - | $5.77 M | $4.89 M |
| Base Salary | - | $890.39 K | $830.77 K |
| Incentive Plan Compensation | - | $2.00 M | $1.50 M |
| All Other Compensation | - | $113.06 K | $49.85 K |
| Stock Award | - | $2.70 M | $2.42 M |
| Anat Ashkenazi Executive Vice President and Chief Financial Officer | - | $4.96 M | $7.60 M |
| Base Salary | - | $634.04 K | $1.03 M |
| Incentive Plan Compensation | - | - | $1.87 M |
| All Other Compensation | - | $38.04 K | $61.85 K |
| Stock Award | - | $3.75 M | $3.69 M |
| Lucas Montarce Executive Vice President and Chief Financial Officer | - | $2.95 M | - |
| Base Salary | - | $664.64 K | - |
| Incentive Plan Compensation | - | $1.11 M | - |
| All Other Compensation | - | $39.88 K | - |
| Stock Award | - | $1.07 M | - |
| Gordon Brooks Interim CFO and Group Vice President - Controller and Corporate Strategy | - | $2.74 M | - |
| Base Salary | - | $558.29 K | - |
| Incentive Plan Compensation | - | $667.66 K | - |
| All Other Compensation | - | $33.50 K | - |
| Stock Award | - | $1.30 M | - |
| Anat Ashkenazi Executive Vice President and Chief Financial Officer | - | - | $7.60 M |
| Base Salary | - | - | - |
| Incentive Plan Compensation | - | - | $1.87 M |
| All Other Compensation | - | - | $61.85 K |
| Stock Award | - | - | $3.69 M |
